Article
Patheon Announces Results Of 2009 Annual Meeting Of Shareholders
May 5, 2009
Patheon Inc. , a global provider of drug development and manufacturing services to the international pharmaceutical industry, recently announced that at its annual meeting of shareholders the following individuals were elected to the Board for the coming year: Claudio F. Bussandri, Paul W. Currie, Ramsey A. Frank, Roy T. Graydon, Peter A. W. Green, Paul S. Levy, Thomas S. Taylor, G. Wesley Voorheis and Derek J. Watchorn.
Ernst & Young LLP was re-appointed as auditors for the 2009 fiscal year.
About Patheon
Patheon Inc. is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies including single-use disposables, Liquid-Filed Hard Capsules and a variety of modified release technologies. Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon's Quick to Clinic™ programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API. Patheon's integrated network strives to ensure that customer products can be launched with confidence globally. For more information visit www.patheon.com.
SOURCE: Patheon Inc.
